The Food and Drug Administration Tuesday issued labeling changes for all testosterone products, adding a warning to prescribers about the drug's potential for abuse.
The revised labels will also contain new information in the abuse and dependence section about adverse effects of abuse, including heart attack, stroke, depression and infertility. Individuals who abuse testosterone may experience withdrawal symptoms like fatigue, loss of appetite and insomnia, according to the report.
The FDA approved testosterone products as hormone replacement therapy for men who have low testosterone as a result of certain medical conditions.
More articles on supply chain:
Supply chain tip of the week: Use evidence-based collaboration to drive clinician engagement
FDA approved Merck's Keytruda as first line treatment against lung cancer
HSCA's 'Total Visibility Project' boosts available product info for GPOs, providers